Rwandan Minister of health Sabin Nsanzimana made the remarks during a virtual weekly media briefing on the multi-country mpox ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...

Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Third Quarter 2024 Financial Results Conference Call. At this time, all ...

Marburg virus causes a viral hemorrhagic fever disease with symptoms similar to those of Ebola. Though there are no approved vaccines ... After it began displaying neurologic signs and could no longer ...

All citizens are advised to be vigilant, keep up to date with local ... Sierra Leone, and treatment may not be available in-country. Avoid contact with wild or stray animals and seek immediate medical ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

Studies exploring the use of viruses to treat cancer date ... treatment. Halassy and her colleagues used two types of viruses — a strain of measles used in vaccines, and vesicular stomatitis ...